Share
CNBC Investing Club

Jim Cramer considers the investment cases for Nautilus Biotechnology and Cyxtera Technologies

On Friday's episode of "Mad Money," host Jim Cramer reviewed the investment cases for Nautilus Biotechnology and Cyxtera Technologies, two companies that viewers had previously called about in search of advice.
07:16
Fri, Jan 21 20227:54 PM EST